文献速递胸部介入PETCT

使用自动机器人手臂(ARA)的实时18F-FDG PET/CT引导活检对既往活检结果不确定的胸部病变的诊断评估:一家三级医疗中心的初步经验

Real-time intraprocedural 18F-FDG PET/CT-guided biopsy using automated robopsy arm (ARA) in the diagnostic evaluation of thoracic lesions with prior inconclusive biopsy results: initial experience from a tertiary health care centre.
PubMed 文献 · Br J Radiol · 2017-10-27

本研究评估了在自动机器人手臂(ARA)引导下实时18F-FDG PET/CT引导活检对既往活检结果不确定的胸部病变的可行性和诊断效用。共纳入25例患者,所有患者均成功获取代表性组织样本,无重大并发症,21例病变病理为恶性,4例为良性,总体诊断率为100%。结论认为该技术可行,可能对既往活检不确定的患者有用。

要点

  • 实时18F-FDG PET/CT引导下经皮穿刺活检在25例胸部病变患者中均成功获取代表性组织样本。
  • 21例病变病理为恶性,4例为良性,无患者需再次活检以最终诊断,总体诊断率100%。
  • 无患者出现重大操作相关并发症。

核心结论

  • 实时18F-FDG PET/CT引导下经皮肺和纵隔病变活检是一种可行技术,可能对既往活检结果不确定的患者有用;18F-FDG PET/CT引导通过特异性靶向有活力的区域并避开坏死/肺不张来减少采样误差,ARA等导航工具被认为有助于准确靶向这些区域。

研究设计与样本

  • 单中心初步经验研究,纳入25例既往至少一次活检结果不确定的胸部病变患者(男18例,女7例;年龄范围13-75岁,平均53.7岁),所有患者均接受实时PET/CT引导下使用ARA(ROBIO-EX,Perfint healthcare Pvt Ltd,金奈,印度)针导航技术的经皮穿刺活检,通过组织病理学和临床随访结果评估操作准确性。

诊断标准与关键数值

  • 总体诊断率100%;25例中21例病变组织病理学为恶性,4例为良性。

临床应用与阅片要点

  • 对于既往活检结果不确定的胸部病变,可考虑使用实时18F-FDG PET/CT引导下ARA辅助经皮穿刺活检,以靶向有活力区域并避开坏死/肺不张。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: The aim of this study was to assess the feasibility and appraise the diagnostic utility of real time 18F-FDG PET/CT-guided biopsy under automated robopsy arm (ARA) guidance for the evaluation of thoracic lesions with prior inconclusive biopsy results.

METHODS: PET/CT-guided biopsy of thoracic lesions was performed in patients who had at least one previous inconclusive biopsy. A total of 25 patients (male:female-18 males, 7 females; age: range, 13-75; mean, 53.7) were included in this study. All these patients underwent percutaneous needle biopsies under real-time PET/CT guidance using ARA (ROBIO-EX, Perfint healthcare Pvt Ltd, Chennai, India) needle navigation technique. Histopathology and clinical follow-up results were reviewed for assessing the accuracy of procedures.

RESULTS: Adequate representative tissue sample could be retrieved in all the patients. No major procedure-related complications were encountered in any patient. Of the 25 procedures, 21 lesions were positive for malignancy and benign findings were observed in the other 4 lesions on histopathology. None of the patients required further biopsy in arriving at a final diagnosis. Overall diagnostic yield of the procedure was 100%.

CONCLUSION: Real time 18F-FDG PET/CT guidance for percutaneous biopsies of lung and mediastinal lesions is a feasible technique with potential utility in patients with previous inconclusive biopsy results. Advances in knowledge: 18F-FDG PET/CT guidance reduces the sampling errors by specifically targeting areas of viability and avoiding necrosis/atelectasis. A navigational tool like ARA is thought to help in accurately targeting these areas.

来源:Br J Radiol,查看原文。版权归原作者所有。

引用

  1. Radhakrishnan RK, Mittal BR, Gorla AKR, et al. Real-time intraprocedural 18F-FDG PET/CT-guided biopsy using automated robopsy arm (ARA) in the diagnostic evaluation of thoracic lesions with prior inconclusive biopsy results: initial experience from a tertiary health care centre. Br J Radiol. 2017. PMID: 28937268. doi:10.1259/bjr.20170258

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。